Adenovirus-mediated gene transfer in the midgestation fetal mouse

Journal of Surgical Research

Volumn 84, Issue 2, 1999, Pages 150-156

  Lipshutz, G S ^a   Flebbe Rehwaldt, L ^a   Gaensler, K M L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenovirus; Gene therapy; In utero

Indexed keywords

ADENOVIRUS; ARTICLE; FETUS; GENE TRANSFER; GENETIC DISORDER; MOUSE; NONHUMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REPORTER GENE;

EID: 0033563696     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5588     Document Type: Article

References (19)

1. Brody S. L., Crystal R. G. Adenovirus-mediated in vivo gene transfer. Ann. NY Acad. Sci. 716:1994;90.
2. Herz J., Gerard R. D. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc. Natl. Acad. Sci. USA. 90:1992;2812.
3. Kay M. A., Landen C. N., Rothenberg S. R., Taylor L. A., Leland F., Wiehle S., Fang B., Bellinger D., Finegold M., Thompson A. R. In vivo hepatic gene therapy: Complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc. Natl. Acad. Sci. USA. 91:1994;2353.
4. Haddada H., Cordier L., Perricaudet M. Gene therapy using adenovirus vectors. Curr. Top. Microbiol. Immunol. 199:1995;297.
5. Zsengeller Z. K., Wert S. E., Hull W. M., Hu X., Yei S., Trapnell B. C., Whitsett J. A. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum. Gene Ther. 64:1995;457.
6. Trapnell B. C., Gorziglia M. Gene therapy using adenoviral vectors. Curr. Opin. Biotechnol. 5:1994;617.
7. Stratford-Perricaudet L. D., Levrero M., Chasse J.-F., Perricaudet M., Briand P. Evaluation of the transfer and expression of an enzyme-encoding gene using a human adenovirus vector. Hum. Gene Ther. 1:1990;241.
8. McCray P. B. Jr., Armstrong K., Zabner J., Miller D. W., Koretzky G. A., Couture L., Robillard J. E., Smith A. E., Welsh M. J. Adenoviral-mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo. J. Clin. Invest. 95:1995;2620.
9. Vincent M. C., Trapnell B. C., Baughman R. P., Wert S. E., Whitsett J. A., Iwamoto H. S. Adenovirus-mediated gene transfer to the respiratory tract of fetal sheep in utero. Hum. Gene Ther. 6:1995;1019.
10. Yang Y., Nunes F. A., Berencsi K., Furth E. E., Gonczol E., Wilson J. M. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA. 91:1994;4407.
11. Holzinger A., Trapnell B. C., Weaver T. E., Whitsett J. A., Iwamoto H. S. Intra-amniotic administration of an adenoviral vector for gene transfer to fetal sheep and mouse tissues. Pediatr. Res. 38:1995;844.
12. Douar A.-M., Adebakin S., Themis M., Pavirani A., Cook T., Coutelle C. Foetal gene delivery in mice by intra-amniotic administration of retroviral producer cells and adenovirus. Gene Ther. 4:1997;883.
13. Addison C. L., Hitt M., Kunsken D., Graham F. L. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors. J. Gen. Virol. 78:1997;1653.
14. Hitt M., Bett A. J., Prevec L., Graham F. L. Part 2: Viruses: Construction and Propagation of human adenovirus vectors. Celis J. E. Cell Biology: A Laboratory Manual. 1994;479-490 Academic Press, San Diego.
15. Graham F. L., Smiley J., Russell W. C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:1977;59.
16. Chardonnet Y., Dales S. Early events in the interaction of adenovirus with HeLa cells: I. Penetration of type 5 and intracellular release of the DNA genome. Virology. 40:1970;462.
17. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265.
18. Wang L., Zoppe M., Hackeng T. M., Griffin J. H., Lee K.-F., Verma I. M. A factor IX-deficient mouse model for hemophilia B gene therapy. Proc. Natl. Acad. Sci. USA. 94:1997;11563.
19. Morsy M. A., Gu M., Motzel S., Zhao J., Lin J., Su Q., Allen H., Franlin L., Parks R. J., Graham F. L. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc. Natl. Acad. Sci. USA. 95:1998;7866.